LIFT With or Without Injection of BM-MNCs

NCT ID: NCT05134168

Last Updated: 2021-11-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

70 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-06-01

Study Completion Date

2021-11-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To improve the outcome of LIFT, some authors used a combined approach of LIFT. Pooled analysis of seven studies including 192 patients revealed a success rate of 83.5 % after combined LIFT approach. The use of bone marrow aspirate concentrate (BMAC) in surgery is not entirely new as it has been widely used in the treatment of bone defects, mandibular reconstruction, maxillary sinus augmentation and in critical limb ischemia.

A previous study concluded that the use of BMAC to augment external anal sphincter repair strengthens wound healing by transferring cells responsible for healing directly to the site of repair. The current study aimed to assess the outcome of local injection of bone marrow mononuclear cells (BM-MNCs) in conjunction with LIFT as compared to LIFT alone in regards to healing rate, time to healing, and ultimate success rate.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anal Fistula

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

LIFT

Patients underwent LIFT proecdure

Group Type ACTIVE_COMPARATOR

LIFT

Intervention Type PROCEDURE

The fistula tract is ligated in the intersphincteric space

LIFT+bone marrow mononuclear cell injection

Patients underwent LIFT with bone marrow mononuclear cell injection

Group Type ACTIVE_COMPARATOR

bone marrow mononuclear cell injection

Intervention Type PROCEDURE

bone marrow mononuclear cells were injected in the intersphincteric space and around the internal opening after ligation and division of the tract

LIFT

Intervention Type PROCEDURE

The fistula tract is ligated in the intersphincteric space

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

bone marrow mononuclear cell injection

bone marrow mononuclear cells were injected in the intersphincteric space and around the internal opening after ligation and division of the tract

Intervention Type PROCEDURE

LIFT

The fistula tract is ligated in the intersphincteric space

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult patients of either gender presented with cryptoglandular trans-sphincteric anal fistula

Exclusion Criteria

* Patients with secondary anal fistula
* Immunocompromised patients
* Patients with previous pelvic radiotherapy
* Pregnant women
* Patients with ASA (American society of anesthesiologists) III or higher.
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Mansoura University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Sameh Emile

Associate professor of surgery

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Mansoura university hospital

Al Mansurah, Dakahlia Governorate, Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Mansoura2022LIFT

Identifier Type: -

Identifier Source: org_study_id